Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases
Abstract
Immunogenicity to the SARS-CoV-2 mRNA vaccines in adolescents and young adults (AYA) with childhood-onset rheumatic diseases (cRD) is unknown. We aimed to evaluate the humoral immunogenicity and safety of the vaccines in our AYA with cRD.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 23, 2022
- Source ID
- 10.1093/rheumatology/keac105
Entities
People
- Amanda Jin Mei Lim
- Camillus Jian Hui Chua
- Jing Yao Leong
- Jinyan Zhang
- Joo Guan Yeo
- Kai Liang Teh
- Katherine Nay Yaung
- Lena Das
- Lin-Fa Wang
- Nursyuhadah Sutamam
- Salvatore Albani
- Sharifah Nur Hazirah
- Shi Huan Tay
- Sook Fun Hoh
- Su Li Poh
- Thaschawee Arkachaisri
- Wan Ni Chia
- Xiaocong Gao
- Xin Mei Ong
- Yun Xin Book
Organizations
- Duke–NUS Medical School
- KK Women's and Children's Hospital
- Ministry of Health
- National Medical Research Council
- National Research Foundation